From: Tourette syndrome and other neurodevelopmental disorders: a comprehensive review
Author (year) | Type of study | N | Age | Comorbidity rate | Scales | Country |
---|---|---|---|---|---|---|
TS in ASD samples | ||||||
Canitano and Vivanti (2007) [44] | Clinical cohort of ASD | 105 | Mean, 12 | 11% TS | DSM IV criteria YGTSS Vineland ABS | Italy |
Baron-Cohen (1999) [43] | Clinical cohort of ASD | 458 | Mean, 11.1 | 6.2% TS | NHIS YGTSS DSM III-IV criteria | England |
Kano et al. (1987) [42] | Clinical cohort of ASD | 76 | NS | 2.6% TS | NS | Japan |
ASD in TS samples | ||||||
Burd et al. (2009) [45] | Clinical cohort of TS | 7288 | NS | 4.6% ASD | DSM IV criteria | Tic international database (author from US) |
Ghanizadeh et al. (2009) [65] | Clinical cohort of TS | 35 | Mean, 11.8 | 2.9% ASD 68.6% ADHD | CBCL K-SADS YGTSS | Iran |
Huisman-van Dijk et al. (2016) [11] | Clinical cohort of TS | 225 | 6–72 | 26% ADHD 20% ASD 35.9% OCD | Conners AQ SCID-I Y-BOCS YGTSS | Germany |